{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:49:05Z","timestamp":1789159745500,"version":"build-2803163510"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005421","name":"Guilan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005421","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and aims<\/jats:title>\n                <jats:p>The John Cunningham virus (JCV) is the established etiological agent of the polyomavirus-associated nephropathy among renal transplant recipients. In the present study, we aimed to determine the probable predictive factors leading to JCV replication in renal transplant patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and methods<\/jats:title>\n                <jats:p>Urine and plasma samples were collected from a total of 120 consecutive renal\u2010transplanted patients without preliminary screening from Jan 2018 to Mar 2019. After DNA extraction, the simultaneous detection and quantification of JCV and BK polyomavirus (BKV) were conducted using a Real-time quantitative PCR method. Moreover, statistical analyses were performed using the statistical software packages, SPSS version 21.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of JCV viruria and viremia among renal transplant recipients were 26 (21.67%) and 20 (16.67%), respectively. A significant association was observed between the JCV and two risk factors, diabetes mellitus (<jats:italic>P<\/jats:italic>\u2009=\u20090.002) and renal stones (<jats:italic>P<\/jats:italic>\u2009=\u20090.015). The prevalence of JCV viremia among recipients who were grafted near time to sampling was significantly higher (<jats:italic>P<\/jats:italic>\u2009=\u20090.02). There was a statistically significant coexistence between BK and JC viruses among our patients (<jats:italic>P<\/jats:italic>\u2009=\u20090.029). The frequency of JCV viruria in males was reported almost three times more than in females (<jats:italic>P<\/jats:italic>\u2009=\u20090.005). The JCV shedding in urine was significantly associated with the tropical steroids like prednisolone acetate, which have been the standard regimen (<jats:italic>P<\/jats:italic>\u2009=\u20090.039). Multivariable analysis revealed duration of post-transplantation (OR, 0.89; <jats:italic>P<\/jats:italic>\u2009=\u20090.038), diabetes mellitus (OR, 1.85; <jats:italic>P<\/jats:italic>\u2009=\u20090.034), and renal stone (OR 1.10; <jats:italic>P<\/jats:italic>\u2009=\u20090.04) as independent risk factors associated with JCV viremia post-renal transplantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>It seems that the discovery of potential risk factors, including immunological and non-immunological elements, may offer a possible preventive or therapeutic approach in the JCV disease episodes. The results of this study may also help clarify the probable clinical risk factors involving in progressive multifocal leukoencephalopathy development.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-022-01843-w","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T07:04:10Z","timestamp":1659942250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Determining host factors contributing to the reactivation of JC virus in kidney transplant recipients"],"prefix":"10.1186","volume":"19","author":[{"given":"Sajedeh","family":"Keykhosravi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4221-8748","authenticated-orcid":false,"given":"Mohammad","family":"Shenagari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Hasan-alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Mosadegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narjes","family":"Noori Goodarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Monfared","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Ashrafkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolou","family":"Hasandokht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"issue":"7712","key":"1843_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S0140-6736(71)91777-6","volume":"297","author":"B Padgett","year":"1971","unstructured":"Padgett B, Zurhein G, Walker D, Eckroade R, Dessel B. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet. 1971;297(7712):1257\u201360.","journal-title":"Lancet"},{"issue":"7712","key":"1843_CR2","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/S0140-6736(71)91776-4","volume":"297","author":"S Gardner","year":"1971","unstructured":"Gardner S, Field A, Coleman D, Hulme B. New human papovavirus (BK) isolated from urine after renal transplantation. Lancet. 1971;297(7712):1253\u20137.","journal-title":"Lancet"},{"issue":"12","key":"1843_CR3","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/jmv.21313","volume":"80","author":"S Delbue","year":"2008","unstructured":"Delbue S, Branchetti E, Boldorini R, Vago L, Zerbi P, Veggiani C, et al. Presence and expression of JCV early gene large T antigen in the brains of immunocompromised and immunocompetent individuals. J Med Virol. 2008;80(12):2147\u201352.","journal-title":"J Med Virol"},{"issue":"3","key":"1843_CR4","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1128\/CMR.05031-11","volume":"25","author":"MW Ferenczy","year":"2012","unstructured":"Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25(3):471\u2013506.","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"1843_CR5","first-page":"939","volume":"4","author":"NU Nqebelele","year":"2019","unstructured":"Nqebelele NU, Dickens C, Dix-Peek T, Duarte R, Naicker S. JC virus and APOL1 risk alleles in black South Africans with hypertension-attributed CKD. Renal Int Rep. 2019;4(7):939\u201345.","journal-title":"Renal Int Rep"},{"issue":"3","key":"1843_CR6","doi-asserted-by":"publisher","first-page":"114859","DOI":"10.1016\/j.diagmicrobio.2019.06.011","volume":"95","author":"B Swinnen","year":"2019","unstructured":"Swinnen B, Saegeman V, Beuselinck K, Wouters A, Cypers G, Meyfroidt G, et al. Predictive value of JC virus PCR in cerebrospinal fluid in the diagnosis of PML. Diagn Microbiol Infect Dis. 2019;95(3):114859.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1843_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/1073274817729901","author":"C Bohra","year":"2017","unstructured":"Bohra C, Sokol L, Dalia S. Progressive multifocal leukoencephalopathy and monoclonal antibodies: a review. Cancer Control. 2017. https:\/\/doi.org\/10.1177\/1073274817729901.","journal-title":"Cancer Control"},{"issue":"5","key":"1843_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1600-6143.2005.00800.x","volume":"5","author":"CD Crowder","year":"2005","unstructured":"Crowder CD, Gyure KA, Drachenberg CB, Werner J, Morales RE, Hirsch HH, et al. Successful outcome of progressive multifocal leukoencephalopathy in a renal transplant patient. Am J Transpl. 2005;5(5):1151\u20138.","journal-title":"Am J Transpl"},{"key":"1843_CR9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.micpath.2016.06.015","volume":"97","author":"H Boukoum","year":"2016","unstructured":"Boukoum H, Nahdi I, Sahtout W, Skiri H, Segondy M, Aouni M. BK and JC virus infections in healthy patients compared to renal transplant recipients in Tunisia. Microb Pathog. 2016;97:204\u20138.","journal-title":"Microb Pathog"},{"issue":"11","key":"1843_CR10","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1097\/TP.0000000000001333","volume":"100","author":"C Lamarche","year":"2016","unstructured":"Lamarche C, Orio J, Collette S, Sen\u00e9cal L, H\u00e9bert M-J, Renoult \u00c9, et al. BK polyomavirus and the transplanted renal: immunopathology and therapeutic approaches. Transplantation. 2016;100(11):2276.","journal-title":"Transplantation"},{"key":"1843_CR11","doi-asserted-by":"crossref","unstructured":"Delbue S, Ferraresso M, Ghio L, Carloni C, Carluccio S, Belingheri M, et al. A review on JC virus infection in renal transplant recipients. Clin Dev Immunol. 2013;2013:926391.","DOI":"10.1155\/2013\/926391"},{"key":"1843_CR12","first-page":"107","volume":"105","author":"BL Padgett","year":"1983","unstructured":"Padgett BL, Walker DL. Virologic and serologic studies of progressive multifocal leukoencephalopathy. Prog Clin Biol Res. 1983;105:107\u201317.","journal-title":"Prog Clin Biol Res"},{"issue":"2","key":"1843_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0733-8619(18)31105-8","volume":"2","author":"BR Brooks","year":"1984","unstructured":"Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin. 1984;2(2):299\u2013313.","journal-title":"Neurol Clin"},{"key":"1843_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcv.2017.09.004","volume":"96","author":"M Shenagari","year":"2017","unstructured":"Shenagari M, Monfared A, Eghtedari H, Pourkazemi A, Hasandokht T, Khosravi M, et al. BK virus replication in renal transplant recipients: analysis of potential risk factors may contribute in reactivation. J Clin Virol. 2017;96:7\u201311.","journal-title":"J Clin Virol"},{"issue":"2","key":"1843_CR15","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1177\/0300060517691795","volume":"45","author":"J Hu","year":"2017","unstructured":"Hu J, Li S, Yang M, Xu L, Zhang X, Zhao H, et al. Incidence, risk factors and the effect of polyomavirus infection in hematopoietic stem cell transplant recipients. J Int Med Res. 2017;45(2):762\u201370.","journal-title":"J Int Med Res"},{"issue":"6","key":"1843_CR16","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1097\/TP.0000000000002414","volume":"103","author":"B H\u00f6cker","year":"2019","unstructured":"H\u00f6cker B, Schneble L, Murer L, Carraro A, Pape L, Kranz B, et al. Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: an international CERTAIN Registry study. Transplantation. 2019;103(6):1224\u201333.","journal-title":"Transplantation"},{"issue":"2","key":"1843_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/cid\/ciy074","volume":"67","author":"H Melliez","year":"2018","unstructured":"Melliez H, Mary-Krause M, Bocket L, Guiguet M, Abgrall S, De Truchis P, et al. Risk of progressive multifocal leukoencephalopathy in the combination antiretroviral therapy era in the French hospital database on human immunodeficiency virus (ANRS-C4). Clin Infect Dis. 2018;67(2):275\u201382.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1843_CR18","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/QAI.0b013e31825a313c","volume":"60","author":"CS Tan","year":"2012","unstructured":"Tan CS, Bord E, Broge TA Jr, Glotzbecker B, Mills H, Gheuens S, et al. Increased program cell death-1 (PD-1) expression on T lymphocytes of patients with progressive multifocal leukoencephalopathy (PML). J Acquir Immune Defic Syndr. 2012;60(3):244.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"1843_CR19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s13365-014-0289-8","volume":"21","author":"DB Clifford","year":"2015","unstructured":"Clifford DB. Progressive multifocal leukoencephalopathy therapy. J Neurovirol. 2015;21(6):632\u20136.","journal-title":"J Neurovirol"},{"issue":"23","key":"1843_CR20","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/bloodadvances.2017008201","volume":"1","author":"EC Neil","year":"2017","unstructured":"Neil EC, DeAngelis LM. Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review. Blood Adv. 2017;1(23):2041\u20135.","journal-title":"Blood Adv"},{"issue":"1","key":"1843_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4103\/0028-3886.60423","volume":"58","author":"V Puri","year":"2010","unstructured":"Puri V, Chaudhry N, Gulati P, Patel N, Tatke M, Sinha S. Progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+ T lymphocytopenia. Neurol India. 2010;58(1):118.","journal-title":"Neurol India"},{"issue":"23","key":"1843_CR22","first-page":"4694","volume":"121","author":"D Rudnicka","year":"2013","unstructured":"Rudnicka D, Oszmiana A, Finch DK, Strickland I, Schofield DJ, Lowe DC, et al. Rituximab causes a polarization of B cells that augments its therapeutic function in NK-cell\u2013mediated antibody-dependent cellular cytotoxicity. Blood J Am Soc Hematol. 2013;121(23):4694\u2013702.","journal-title":"Blood J Am Soc Hematol"},{"issue":"Pt 12","key":"1843_CR23","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1099\/vir.0.023184-0","volume":"91","author":"LJ Marshall","year":"2010","unstructured":"Marshall LJ, Dunham L, Major EO. Transcription factor Spi-B binds unique sequences present in the tandem repeat promoter\/enhancer of JC virus and supports viral activity. J Gen Virol. 2010;91(Pt 12):3042.","journal-title":"J Gen Virol"},{"issue":"12","key":"1843_CR24","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1348-0421.2010.00278.x","volume":"54","author":"S Nukuzuma","year":"2010","unstructured":"Nukuzuma S, Nakamichi K, Kameoka M, Sugiura S, Nukuzuma C, Miyoshi I, et al. Efficient propagation of progressive multifocal leukoencephalopathy-type JC virus in COS-7-derived cell lines stably expressing Tat protein of human immunodeficiency virus type 1. Microbiol Immunol. 2010;54(12):758\u201362.","journal-title":"Microbiol Immunol"},{"issue":"4","key":"1843_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11481-019-09877-8","volume":"14","author":"A Khalili","year":"2019","unstructured":"Khalili A, Craigie M, Donadoni M, Sariyer IK. Host-immune interactions in JC virus reactivation and development of progressive multifocal leukoencephalopathy (PML). J Neuroimmune Pharmacol. 2019;14(4):649\u201360.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"1843_CR26","doi-asserted-by":"publisher","first-page":"e14630","DOI":"10.1371\/journal.pone.0014630","volume":"6","author":"IK Sariyer","year":"2011","unstructured":"Sariyer IK, Khalili K. Regulation of human neurotropic JC virus replication by alternative splicing factor SF2\/ASF in glial cells. PLoS ONE. 2011;6(1):e14630.","journal-title":"PLoS ONE"},{"issue":"1","key":"1843_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-015-0426-x","volume":"12","author":"M Craigie","year":"2015","unstructured":"Craigie M, Regan P, Otalora Y-L, Sariyer IK. Molecular interplay between T-Antigen and splicing factor, arginine\/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells. Virol J. 2015;12(1):1\u20137.","journal-title":"Virol J"},{"issue":"21","key":"1843_CR28","doi-asserted-by":"publisher","first-page":"10506","DOI":"10.1128\/JVI.01355-06","volume":"80","author":"V Ravichandran","year":"2006","unstructured":"Ravichandran V, Sabath BF, Jensen PN, Houff SA, Major EO. Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropism. J Virol. 2006;80(21):10506\u201313.","journal-title":"J Virol"},{"issue":"8","key":"1843_CR29","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/nar\/21.8.1959","volume":"21","author":"PN Ranganathan","year":"1993","unstructured":"Ranganathan PN, Khalili K. The transcriptional enhancer element, x B, regulates promoter activity of the human neurotropic virus, JCV, in cells derived from the CNS. Nucleic Acids Res. 1993;21(8):1959\u201364.","journal-title":"Nucleic Acids Res"},{"issue":"Pt 8","key":"1843_CR30","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1099\/vir.0.011072-0","volume":"90","author":"MR Stettner","year":"2009","unstructured":"Stettner MR, Nance JA, Wright CA, Kinoshita Y, Kim W-K, Morgello S, et al. SMAD proteins of oligodendroglial cells regulate transcription of JC virus early and late genes coordinately with the Tat protein of human immunodeficiency virus type 1. J Gen Virol. 2009;90(Pt 8):2005.","journal-title":"J Gen Virol"},{"issue":"9","key":"1843_CR31","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1097\/00007890-200105150-00020","volume":"71","author":"P Randhawa","year":"2001","unstructured":"Randhawa P, Baksh F, Aoki N, Tschirhart D, Finkelstein S. JC virus infection in allograft renals: analysis by polymerase chain reaction and immunohistochemistry. Transplantation. 2001;71(9):1300\u20133.","journal-title":"Transplantation"},{"issue":"11","key":"1843_CR32","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1097\/01.TP.0000090749.42791.14","volume":"76","author":"A Kazory","year":"2003","unstructured":"Kazory A, Ducloux D, Chalopin J-M, Angonin R, Fontani\u00e8re B, Moret H. The first case of JC virus allograft nephropathy. Transplantation. 2003;76(11):1653\u20135.","journal-title":"Transplantation"},{"issue":"4","key":"1843_CR33","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/jmv.20037","volume":"72","author":"MC Wen","year":"2004","unstructured":"Wen MC, Wang CL, Wang M, Cheng CH, Wu MJ, Chen CH, et al. Association of JC virus with tubulointerstitial nephritis in a renal allograft recipient. J Med Virol. 2004;72(4):675\u20138.","journal-title":"J Med Virol"},{"issue":"1","key":"1843_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1399-3062.2010.00567.x","volume":"13","author":"G Kantarci","year":"2011","unstructured":"Kantarci G, Eren Z, Demira\u011f A, Dogan I, Cakalagaoglu F, Yilmaz G. JC virus-associated nephropathy in a renal transplant recipient and comparative analysis of previous cases. Transpl Infect Dis. 2011;13(1):89\u201392.","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"1843_CR35","first-page":"245","volume":"10","author":"JC Garces","year":"2010","unstructured":"Garces JC. BK virus\u2013associated nephropathy in renal transplant recipients. Ochsner J. 2010;10(4):245\u20139.","journal-title":"Ochsner J"},{"issue":"5","key":"1843_CR36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1681\/ASN.2010080877","volume":"22","author":"XS Cheng","year":"2011","unstructured":"Cheng XS, Bohl DL, Storch GA, Ryschkewitsch C, Gaudreault-Keener M, Major EO, et al. Inhibitory interactions between BK and JC virus among renal transplant recipients. J Am Soc Nephrol. 2011;22(5):825\u201331.","journal-title":"J Am Soc Nephrol"},{"key":"1843_CR37","doi-asserted-by":"publisher","first-page":"197860","DOI":"10.1016\/j.virusres.2020.197860","volume":"278","author":"I Hussain","year":"2020","unstructured":"Hussain I, Tasneem F, Gilani US, Arshad MI, ul Haque MF, Abbas Z, et al. Human BK and JC polyomaviruses: molecular insights and prevalence in Asia. Virus Res. 2020;278:197860.","journal-title":"Virus Res"},{"key":"1843_CR38","doi-asserted-by":"crossref","unstructured":"Yoon S-H, Cho J-H, Jung H-Y, Choi J-Y, Park S-H, Kim Y-L, et al. Clinical impact of BK virus surveillance on outcomes in renal transplant recipients. In: Transplantation proceedings: Elsevier; 2015. p. 660\u20135.","DOI":"10.1016\/j.transproceed.2014.11.051"},{"issue":"2","key":"1843_CR39","first-page":"84","volume":"5","author":"SM Bozorgi","year":"2012","unstructured":"Bozorgi SM, Tahaei SME, Mohebbi SR, Sahba N, Damavand B, Romani S, et al. Molecular prevalence of JC virus in Tehran, Iran. Gastroenterol Hepatol Bed Bench. 2012;5(2):84.","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"1","key":"1843_CR40","first-page":"61","volume":"160","author":"F Sadeghi","year":"2015","unstructured":"Sadeghi F, Salehi-Vaziri M, Ghodsi SM, Alizadeh A, Bokharaei-Salim F, Saroukalaei ST, et al. Prevalence of JC polyomavirus large T antigen sequences among Iranian patients with central nervous system tumors. Adv Virol. 2015;160(1):61\u20138.","journal-title":"Adv Virol"},{"issue":"7","key":"1843_CR41","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2217\/fvl-2016-0015","volume":"11","author":"K Pourjabari","year":"2016","unstructured":"Pourjabari K, Makvandi M, Kaydani G, Shahbazian H, Samarbaf-Zadeh AR. Prevalence, reactivation and genotyping of John Cunningham virus among end-stage renal disease and renal transplant patients. Futur Virol. 2016;11(7):489\u201396.","journal-title":"Futur Virol"},{"issue":"2","key":"1843_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jcv.2010.06.017","volume":"49","author":"MI Husseiny","year":"2010","unstructured":"Husseiny MI, Anastasi B, Singer J, Lacey SF. A comparative study of Merkel cell, BK and JC polyomavirus infections in renal transplant recipients and healthy subjects. J Clin Virol. 2010;49(2):137\u201340.","journal-title":"J Clin Virol"},{"issue":"7","key":"1843_CR43","first-page":"916","volume":"16","author":"S Taheri","year":"2011","unstructured":"Taheri S, Kafilzadeh F, Shafa M, Yaran M, Mortazavi M, Seirafian S, et al. Comparison of polyomavirus (BK virus and JC viruses) viruria in renal transplant recipients with and without renal dysfunction. J Res Med Sci. 2011;16(7):916.","journal-title":"J Res Med Sci"},{"issue":"8","key":"1843_CR44","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/jcp.2009.074864","volume":"63","author":"BK Saundh","year":"2010","unstructured":"Saundh BK, Tibble S, Baker R, Sasnauskas K, Harris M, Hale A. Different patterns of BK and JC polyomavirus reactivation following renal transplantation. J Clin Pathol. 2010;63(8):714\u20138.","journal-title":"J Clin Pathol"},{"issue":"7","key":"1843_CR45","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1432-2277.2009.00847.x","volume":"22","author":"I Helanter\u00e4","year":"2009","unstructured":"Helanter\u00e4 I, Ortiz F, Auvinen E, R\u00e4is\u00e4nen-Sokolowski A, Lappalainen M, Lautenschlager I, et al. Polyomavirus BK and JC infections in well matched Finnish renal transplant recipients. Transpl Int. 2009;22(7):688\u201393.","journal-title":"Transpl Int"},{"issue":"6","key":"1843_CR46","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1399-3062.2011.00614.x","volume":"13","author":"E Pires","year":"2011","unstructured":"Pires E, Bernardino-Vallinoto C, Alves D, Migone S, Machado L, Ishak M, et al. Prevalence of infection by JC and BK polyomaviruses in renal transplant recipients and patients with chronic renal disease. Transpl Infect Dis. 2011;13(6):633\u20137.","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"1843_CR47","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/jmv.21951","volume":"83","author":"C Mengelle","year":"2011","unstructured":"Mengelle C, Kamar N, Mansuy JM, Sandres-Saun\u00e9 K, Legrand-Abravanel F, Mi\u00e9doug\u00e9 M, et al. JC virus DNA in the peripheral blood of renal transplant patients: A 1-year prospective follow-up in France. J Med Virol. 2011;83(1):132\u20136.","journal-title":"J Med Virol"},{"issue":"2","key":"1843_CR48","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/jmv.20442","volume":"77","author":"P Randhawa","year":"2005","unstructured":"Randhawa P, Uhrmacher J, Pasculle W, Vats A, Shapiro R, Eghtsead B, et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol. 2005;77(2):238\u201343.","journal-title":"J Med Virol"},{"issue":"3","key":"1843_CR49","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/01.tp.0000269706.59977.a5","volume":"84","author":"CB Drachenberg","year":"2007","unstructured":"Drachenberg CB, Hirsch HH, Papadimitriou JC, Gosert R, Wali RK, Munivenkatappa R, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation. Transplantation. 2007;84(3):323\u201330.","journal-title":"Transplantation"},{"issue":"1","key":"1843_CR50","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.amjsurg.2009.03.017","volume":"200","author":"W-Y Yin","year":"2010","unstructured":"Yin W-Y, Lu M-C, Lee M-C, Liu S-C, Lin T-Y, Lai N-S. A correlation between polyomavirus JC virus quantification and genotypes in renal transplantation. Am J Surg. 2010;200(1):53\u20138.","journal-title":"Am J Surg"},{"issue":"4","key":"1843_CR51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000349896","volume":"56","author":"ACJ Zalona","year":"2013","unstructured":"Zalona ACJ, Varella RB, Takiya CM, Goncalves RT, Zalis MG, Santoro-Lopes G. A qualitative seminested PCR assay as an alternative to urine cytology for BK polyomavirus screening after renal transplantation. Intervirology. 2013;56(4):249\u201352.","journal-title":"Intervirology"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01843-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-022-01843-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01843-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T08:05:27Z","timestamp":1659945927000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-022-01843-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,8]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1843"],"URL":"https:\/\/doi.org\/10.1186\/s12985-022-01843-w","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,8]]},"assertion":[{"value":"27 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project proposal received ethical approval from the Research Committee and the Ethics Committee at the Guilan University of Medical Sciences through the approval ID of \u201cIR.GUMS.REC.1397.135\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors of this manuscript have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}